Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non …
Background Randomised comparative data on efficacy and safety of second-line
antiretroviral therapy (ART) after failure of non-nucleoside reverse transcriptase inhibitors …
antiretroviral therapy (ART) after failure of non-nucleoside reverse transcriptase inhibitors …
Dolutegravir for second-line antiretroviral therapy: the beat goes on
N Shangase, T Kufa - The Lancet Global Health, 2024 - thelancet.com
Dolutegravir (DTG) has been recommended by the WHO for use in second-line antiretroviral
therapy (ART) regimens since 2019. 1 The recommendation followed the findings of the …
therapy (ART) regimens since 2019. 1 The recommendation followed the findings of the …
[引用][C] Second-line HIV treatments for adults in LMICs
EC João - The Lancet HIV, 2024 - thelancet.com
The majority of people living with HIV reside in lowincome and middle-income countries
(LMICs), settings in which antiretroviral HIV treatment is challenging due to scarce treatment …
(LMICs), settings in which antiretroviral HIV treatment is challenging due to scarce treatment …